InvestSMART

Enlitic Inc (ASX: ENL) - Announcements

- Current share price for ENL : $0.031

ASX company news and announcements for Enlitic Inc (ENL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Enlitic Inc (ENL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Enlitic Inc (ENL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Enlitic Inc (ENL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$23 Investor Presentation 5 May 2025 9:39AM $0.048 $0.031 fallen by 35.42%
$23 MOU signed with GE HealthCare and A$10m capital raise 5 May 2025 9:39AM $0.048 $0.031 fallen by 35.42%
$23 Trading Halt 1 May 2025 8:15AM $0.048 $0.031 fallen by 35.42%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 4:13PM $0.048 $0.031 fallen by 35.42%
$23 New migration & Ensight agreements secured 23 Apr 2025 8:37AM $0.050 $0.031 fallen by 38%
$23 Change of addresses of AU registered office & share registry 14 Apr 2025 8:21AM $0.051 $0.031 fallen by 39.22%
$23 Notification of cessation of securities - ENL 11 Apr 2025 8:23AM $0.054 $0.031 fallen by 42.59%
$23 Application for quotation of securities - ENL 9 Apr 2025 9:52AM $0.056 $0.031 fallen by 44.64%
$23 Notification regarding unquoted securities - ENL 9 Apr 2025 9:50AM $0.056 $0.031 fallen by 44.64%
$23 GE HealthCare launches new Genesis portfolio with Enlitic 5 Mar 2025 8:52AM $0.090 $0.031 fallen by 65.56%
$23 Updated Appendices 3X and 3Y 28 Feb 2025 4:26PM $0.095 $0.031 fallen by 67.37%
$23 Corporate Governance Statement & Appendix 4G 28 Feb 2025 3:27PM $0.095 $0.031 fallen by 67.37%
$23 Appendix 4E & 2024 Annual Report 28 Feb 2025 3:26PM $0.095 $0.031 fallen by 67.37%
$23 Update - Notification of cessation of securities - ENL 19 Feb 2025 8:43AM $0.085 $0.031 fallen by 63.53%
$23 Notification of cessation of securities - ENL 19 Feb 2025 8:42AM $0.085 $0.031 fallen by 63.53%
$23 Update - Notification regarding unquoted securities - ENL 19 Feb 2025 8:37AM $0.085 $0.031 fallen by 63.53%
$23 Enlitic Collaborates with GE HealthCare 18 Feb 2025 8:54AM $0.058 $0.031 fallen by 46.55%
$23 Update - Application for quotation of securities - ENL 7 Feb 2025 10:18AM $0.061 $0.031 fallen by 49.18%
$23 Application for quotation of securities - ENL 7 Feb 2025 10:15AM $0.061 $0.031 fallen by 49.18%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 9:09AM $0.060 $0.031 fallen by 48.33%
$23 Change of Director's Interest Notice 22 Jan 2025 9:31AM $0.058 $0.031 fallen by 46.55%
$23 Change of Director's Interest Notice 22 Jan 2025 9:30AM $0.058 $0.031 fallen by 46.55%
$23 Change of Director's Interest Notice 22 Jan 2025 9:29AM $0.058 $0.031 fallen by 46.55%
$23 Change of Director's Interest Notice 22 Jan 2025 9:29AM $0.058 $0.031 fallen by 46.55%
$23 Notification regarding unquoted securities - ENL 22 Jan 2025 9:26AM $0.058 $0.031 fallen by 46.55%

101 - 125 of 330 results

Page 5 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.